Cargando…
Nanoparticle Vaccines Based on the Receptor Binding Domain (RBD) and Heptad Repeat (HR) of SARS-CoV-2 Elicit Robust Protective Immune Responses
Various vaccine strategies have been proposed in response to the global COVID-19 pandemic, each with unique strategies for eliciting immune responses. Here, we developed nanoparticle vaccines by covalently conjugating the self-assembled 24-mer ferritin to the receptor binding domain (RBD) and/or hep...
Autores principales: | Ma, Xiancai, Zou, Fan, Yu, Fei, Li, Rong, Yuan, Yaochang, Zhang, Yiwen, Zhang, Xiantao, Deng, Jieyi, Chen, Tao, Song, Zheng, Qiao, Yidan, Zhan, Yikang, Liu, Jun, Zhang, Junsong, Zhang, Xu, Peng, Zhilin, Li, Yuzhuang, Lin, Yingtong, Liang, Liting, Wang, Guanwen, Chen, Yingshi, Chen, Qier, Pan, Ting, He, Xin, Zhang, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7687490/ https://www.ncbi.nlm.nih.gov/pubmed/33275896 http://dx.doi.org/10.1016/j.immuni.2020.11.015 |
Ejemplares similares
-
Differential efficiencies to neutralize the novel mutants B.1.1.7 and 501Y.V2 by collected sera from convalescent COVID-19 patients and RBD nanoparticle-vaccinated rhesus macaques
por: Li, Rong, et al.
Publicado: (2021) -
Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants
por: Chen, Ran, et al.
Publicado: (2022) -
Brd4 Regulates the Homeostasis of CD8(+) T-Lymphocytes and Their Proliferation in Response to Antigen Stimulation
por: Peng, Zhilin, et al.
Publicado: (2021) -
A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
por: Yuan, Yaochang, et al.
Publicado: (2022) -
Pam2CSK4-adjuvanted SARS-CoV-2 RBD nanoparticle vaccine induces robust humoral and cellular immune responses
por: Qiao, Yidan, et al.
Publicado: (2022)